HAVCR1 and kidney disorder: One strategy to move further forward to understand the clinical utility and interpretation of plasma KIM‐1 in the context of APAP overdose is to define normal reference ranges and establish cut‐off values in healthy population and populations with renal disease and evaluate whether there is any impact of gender, ethnicity, and diurnal variation on plasma KIM‐1 expression levels.